UMCG

NEWS

    • Breaking news: online publication of clinical phase I study in breast cancer

      Breaking news: online publication of clinical phase I study in breast cancer

      The paper on the clinical phase I study on image-guided surgery using bevacizumab-IRDye800CW in patients with primary breast cancer is published online at the website of Clinical Cancer Research: http://clincancerres.aacrjournals.org/content/early/2016/11/09/1078-0432.CCR-16-0437.  The study was funded by CTMM MAMMOTH project and the ERC OnQView grant The study was executed at the University Medical Center Groningen and University Medical Center Utrecht Tumor-specificRead more →

    • San Antonio Breast Cancer Conference 2016

      San Antonio Breast Cancer Conference 2016

      Two posters accepted at San Antonio Breast Cancer Conference 2016 Validation of a Chinese nomogram with a Dutch breast cancer population: Excellent prediction of the probability of axillary lymph node metastasis  Presentation by: Siqi Qiu MARGIN-I study: Phase II in-human dose escalation study of the optical molecular imaging tracer bevacizumab-800cw for molecular fluorescence guided surgery inRead more →

    • Publication of the review ‘Emerging Targets in Photopharmacology’

      Publication of the review ‘Emerging Targets in Photopharmacology’

      We are pleased to inform you that the review called ‘Emerging Targets in Photopharmacology’  is published online at the website of the Angewandte Chemie international edition. The paper can be found here.Read more →

    • Nobel Prize chemistry 2016  prof. Ben Feringa: Congratulations!

      Nobel Prize chemistry 2016 prof. Ben Feringa: Congratulations!

      The OMIG group congratulates professor Ben Feringa and his group with the Nobel Prize for Chemistry 2016 and we are looking forward to new exciting collaborations on photopharmacological applications in optical cancer treatment.Read more →

    Our Team

    • Gooitzen van Dam
      Principal Investigator

    • Wouter Nagengast
      Principal Investigator

    • Max Witjes
      Principal Investigator

    • Schelto Kruijff
      Principal Investigator